MC Innovation Technology has recently declared the successful closure of its Pre-A+ round financing, raising hundreds of millions of yuan. This round has attracted investment from multiple institutions, with WinX Capital serving as the sole financial advisor. The proceeds from this financing will be allocated towards accelerating registered clinical trials, driving technological advancements, establishing production lines and quality systems, and expanding market reach.

Since its inception in China in 2022, MC Innovation Technology has witnessed remarkable growth and now stands at the forefront of the AI medical robotics sector in terms of financing. The company is firmly rooted in the AI + multi-energy source intelligent hardware pathway, pioneering innovations in the realm of skin tissue treatment. It has acquired expertise in the core technologies of AI algorithms and hardware matrices, effectively conquering the dual hurdles of precision and safety. MC has established a comprehensive ecosystem with a closed-loop structure to foster the coordinated growth of both clinical and industrial sectors.

Looking ahead, MC Innovation Technology plans to capitalize on policy and financial backing to deepen technological integration, achieve technological leaps, and drive industrial upgrades.